Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

A Lesson on Outsourcing: The NECC Fungal Meningitis Outbreak

This article was originally published in The Gold Sheet

Executive Summary

You may also be interested in...



Two-Decade Old US Interstate Compounding Provision Stayed For More Comments

Responding to court ruling, US FDA will explore what it will cost compounding pharmacies to submit to increased state restrictions and oversight of out-of-state compounding quality under a standard MOU that Congress required decades ago.

FDA Again Proposes To Advance Outsourcing Sector With Center Of Excellence

The US FDA’s FY 2020 budget request calls for funding to help advance the emerging drug compounding outsourcing sector, as did the FY 2019 request. The money would bring more training, specially tailored GMP requirements and a center of excellence.

Regulatory Updates in Brief

EU issues GMP Annex 16 on qualified persons; New ISO-9001 standard released; FDA extends comments for “established conditions” guidance; USP to revise General Chapter <797> on pharmaceutical compounding for sterile preparations; and FDA issues guidance on adverse event reporting for 503(b) outsourcing facilities.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS000646

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel